Literature DB >> 24089522

Impaired phosphorylation and ubiquitination by p70 S6 kinase (p70S6K) and Smad ubiquitination regulatory factor 1 (Smurf1) promote tribbles homolog 2 (TRIB2) stability and carcinogenic property in liver cancer.

Jiayi Wang1, Yue Zhang2, Wenhao Weng1, Yongxia Qiao3, Lifang Ma1, Weifan Xiao2, Yongchun Yu2, Qiuhui Pan4, Fenyong Sun5.   

Abstract

Tribbles homolog 2 (TRIB2) is critical for both solid and non-solid malignancies. Recently, TRIB2 was identified as a liver cancer-specific Wnt/β-catenin signaling downstream target and is functionally important for liver cancer cell survival and transformation. TRIB2 functions as a protein that interacts with E3 ubiquitin ligases and thereby modulates protein stability of downstream effectors. However, the regulation underlying TRIB2 protein stability per se has not yet been reported. In this study, we found that TRIB2 was up-regulated and exhibited high stability in liver cancer cells compared with other cells. We performed a structure-function analysis of TRIB2 and identified a domain (amino acids 1-5) at the N terminus that interacted with the E3 ubiquitin ligase Smurf1 and was critical for protein stability. Deletion of this domain extended TRIB2 half-life time accompanied with a more significant malignant property compared with wild type TRIB2. Furthermore, Smurf1-mediated ubiquitination required phosphorylation of TRIB2 by p70 S6 kinase (p70S6K) via another domain (amino acids 69-85) that is also essential for correct TRIB2 subcellular localization. Mutation of Ser-83 diminished p70S6K-induced phosphorylation of TRIB2. Moreover, the high stability of TRIB2 may be due to the fact that both p70S6K and Smurf1 were down-regulated and negatively correlated with TRIB2 expression in both liver cancer tissues and established liver cancer cell lines. Taken together, impaired phosphorylation and ubiquitination by p70S6K and Smurf1 increase the protein stability of TRIB2 in liver cancer and thus may be helpful in the development of diagnosis and treatment strategies against this malignant disease.

Entities:  

Keywords:  E3 Ubiquitin Ligase; Gene Regulation; Hepatocellular Carcinoma; Phosphorylation; Post-translational Modification

Mesh:

Substances:

Year:  2013        PMID: 24089522      PMCID: PMC3837113          DOI: 10.1074/jbc.M113.503292

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

Review 1.  The many faces of beta-TrCP E3 ubiquitin ligases: reflections in the magic mirror of cancer.

Authors:  Serge Y Fuchs; Vladimir S Spiegelman; K G Suresh Kumar
Journal:  Oncogene       Date:  2004-03-15       Impact factor: 9.867

2.  E2 conjugating enzymes must disengage from their E1 enzymes before E3-dependent ubiquitin and ubiquitin-like transfer.

Authors:  Ziad M Eletr; Danny T Huang; David M Duda; Brenda A Schulman; Brian Kuhlman
Journal:  Nat Struct Mol Biol       Date:  2005-09-04       Impact factor: 15.369

3.  TRB3 links the E3 ubiquitin ligase COP1 to lipid metabolism.

Authors:  Ling Qi; Jose E Heredia; Judith Y Altarejos; Robert Screaton; Naomi Goebel; Sherry Niessen; Ian X Macleod; Chong Wee Liew; Rohit N Kulkarni; James Bain; Christopher Newgard; Michael Nelson; Ronald M Evans; John Yates; Marc Montminy
Journal:  Science       Date:  2006-06-23       Impact factor: 47.728

4.  Degradation of the tumor suppressor Smad4 by WW and HECT domain ubiquitin ligases.

Authors:  Anita Morén; Takeshi Imamura; Kohei Miyazono; Carl-Henrik Heldin; Aristidis Moustakas
Journal:  J Biol Chem       Date:  2005-04-06       Impact factor: 5.157

5.  A SMAD ubiquitin ligase targets the BMP pathway and affects embryonic pattern formation.

Authors:  H Zhu; P Kavsak; S Abdollah; J L Wrana; G H Thomsen
Journal:  Nature       Date:  1999-08-12       Impact factor: 49.962

6.  Differential subcellular localisation of two isoforms of p70 S6 protein kinase.

Authors:  P J Coffer; J R Woodgett
Journal:  Biochem Biophys Res Commun       Date:  1994-01-28       Impact factor: 3.575

7.  Ubiquitin ligase Smurf1 controls osteoblast activity and bone homeostasis by targeting MEKK2 for degradation.

Authors:  Motozo Yamashita; Sai-Xia Ying; Gen-Mu Zhang; Cuiling Li; Steven Y Cheng; Chu-Xia Deng; Ying E Zhang
Journal:  Cell       Date:  2005-04-08       Impact factor: 41.582

8.  Tribbles homolog 2 inactivates C/EBPalpha and causes acute myelogenous leukemia.

Authors:  Karen Keeshan; Yiping He; Bas J Wouters; Olga Shestova; Lanwei Xu; Hong Sai; Carlos G Rodriguez; Ivan Maillard; John W Tobias; Peter Valk; Martin Carroll; Jon C Aster; Ruud Delwel; Warren S Pear
Journal:  Cancer Cell       Date:  2006-11       Impact factor: 31.743

9.  Balancing BMP signaling through integrated inputs into the Smad1 linker.

Authors:  Gopal Sapkota; Claudio Alarcón; Francesca M Spagnoli; Ali H Brivanlou; Joan Massagué
Journal:  Mol Cell       Date:  2007-02-09       Impact factor: 17.970

10.  Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas.

Authors:  A de La Coste; B Romagnolo; P Billuart; C A Renard; M A Buendia; O Soubrane; M Fabre; J Chelly; C Beldjord; A Kahn; C Perret
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-21       Impact factor: 11.205

View more
  14 in total

1.  Suppression of the Smurf1 Expression Inhibits Tumor Progression in Gliomas.

Authors:  Hao Chang; Jingning Zhang; Zengli Miao; Yasuo Ding; Xing Xu; Xudong Zhao; Peng Xu; Qing Wang; Yuchang Lin
Journal:  Cell Mol Neurobiol       Date:  2017-03-20       Impact factor: 5.046

2.  Oncogenic TRIB2 interacts with and regulates PKM2 to promote aerobic glycolysis and lung cancer cell procession.

Authors:  Yuan-Rong Liu; Dan-Dan Song; Dong-Min Liang; You-Jie Li; Yun-Fei Yan; Hong-Fang Sun; Mei-Ling Zhang; Jin-Xia Hu; Yu-Long Zhao; Yan Liang; Yan-Mei Li; Zhen Yang; Ran-Ran Wang; Hou-Feng Zheng; Pingyu Wang; Shu-Yang Xie
Journal:  Cell Death Discov       Date:  2022-07-05

3.  Smurf1-mediated axin ubiquitination requires Smurf1 C2 domain and is cell cycle-dependent.

Authors:  Cong Fei; Xiaoli He; Sichun Xie; Haofei Miao; Zhilei Zhou; Lin Li
Journal:  J Biol Chem       Date:  2014-04-03       Impact factor: 5.157

4.  Use of signals of positive and negative selection to distinguish cancer genes and passenger genes.

Authors:  László Bányai; Maria Trexler; Krisztina Kerekes; Orsolya Csuka; László Patthy
Journal:  Elife       Date:  2021-01-11       Impact factor: 8.140

5.  Doxorubicin induces apoptosis by targeting Madcam1 and AKT and inhibiting protein translation initiation in hepatocellular carcinoma cells.

Authors:  Jiayi Wang; Lifang Ma; Xun Tang; Xiao Zhang; Yongxia Qiao; Yuling Shi; Yanfeng Xu; Zhongyong Wang; Yongchun Yu; Fenyong Sun
Journal:  Oncotarget       Date:  2015-09-15

6.  TRIB1 Is Regulated Post-Transcriptionally by Proteasomal and Non-Proteasomal Pathways.

Authors:  Sébastien Soubeyrand; Amy Martinuk; Paulina Lau; Ruth McPherson
Journal:  PLoS One       Date:  2016-03-28       Impact factor: 3.240

Review 7.  Tribbles in the 21st Century: The Evolving Roles of Tribbles Pseudokinases in Biology and Disease.

Authors:  Patrick A Eyers; Karen Keeshan; Natarajan Kannan
Journal:  Trends Cell Biol       Date:  2016-11-28       Impact factor: 20.808

Review 8.  SMURF1, a promoter of tumor cell progression?

Authors:  Qin Xia; Yang Li; Da Han; Lei Dong
Journal:  Cancer Gene Ther       Date:  2020-11-17       Impact factor: 5.987

Review 9.  The Critical Role of TRIB2 in Cancer and Therapy Resistance.

Authors:  Victor Mayoral-Varo; Lucía Jiménez; Wolfgang Link
Journal:  Cancers (Basel)       Date:  2021-05-30       Impact factor: 6.639

Review 10.  Tribbles homolog 2 (Trib2), a pseudo serine/threonine kinase in tumorigenesis and stem cell fate decisions.

Authors:  Yu Fang; Angelina Olegovna Zekiy; Farhoodeh Ghaedrahmati; Anton Timoshin; Maryam Farzaneh; Amir Anbiyaiee; Seyed Esmaeil Khoshnam
Journal:  Cell Commun Signal       Date:  2021-04-01       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.